课题基金 / 基金详情

Deciphering the molecular basis of T1D in human cells using functional genomics

Deciphering the molecular basis of T1D in human cells using functional genomics
使用功能基因组学解读人类细胞中 T1D 的分子基础
批准号:
9228681
负责人:
STEVEN A CARR
金额:
$416.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2021-05-31

项目摘要

项目成果

STEVEN A CARR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Abstract Type 1 Diabetes (T1D) is an autoimmune disease in which the insulin-producing beta cells of the pancreas are destroyed. These beta cells are specifically targeted for destruction by autoreactive T cells, which manage to escape the normal elimination mechanisms in the thymus. Although it is clear that besides environmental factors a strong genetic component is involved, the underlying basis for autoimmune T1D is not well understood. GWAS for a number of diseases, including T1D, have recently highlighted regulatory DNA regions rather than protein coding sequences as "hot spots" where single nucleotide polymorphisms (SNPs) as causal variants can be found. Our long term goal is to decipher the molecular mechanism of genotype-phenotype causalities in T1D. Our overall objective is the in depth characterization of DNA regulatory elements and their risk variants that underlie T1D susceptibility on a molecular and functional level. Our central hypothesis is that T1D associated SNPs alter the function of cell type-specific DNA regulatory elements. Guided by strong preliminary data, we will approach this hypothesis from 3 complementary angles: We will use state-of-the-art and novel computational strategies to fine map T1D GWAS SNPs to candidate causal variants (Aim 1). We will characterize the mechanism of action of causal candidates SNPs by utilizing a combination of functional genomics and proteomics (Aim 2). Finally, we will determine the functional relevance of causal variants in T1D-relevant human(-ized) systems (Aim 3). This approach is highly innovative and will provide the first in depth functional characterization of DNA regulatory elements and their risk variants that underlie T1D susceptibility. Our studies will provide a significant shift from the correlative to the functional investigation of human T1D susceptibility. Ultimately, such knowledge has the potential to translate to novel approaches to predict, prevent and potentially to treat T1D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
  • 批准号:
    10459716
  • 项目类别:
  • 资助金额:
    $108.43万
  • 财政年份:
    2022
  • 负责人:
    STEVEN A CARR
  • 依托单位:
Center of Excellence for High Throughput Proteogenomic Characterization
  • 批准号:
    10643840
  • 项目类别:
  • 资助金额:
    $106.63万
  • 财政年份:
    2022
  • 负责人:
    STEVEN A CARR
  • 依托单位:
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
  • 批准号:
    10643902
  • 项目类别:
  • 资助金额:
    $103.23万
  • 财政年份:
    2022
  • 负责人:
    STEVEN A CARR
  • 依托单位:
Center of Excellence for High Throughput Proteogenomic Characterization
  • 批准号:
    10438235
  • 项目类别:
  • 资助金额:
    $108.81万
  • 财政年份:
    2022
  • 负责人:
    STEVEN A CARR
  • 依托单位:
海外基金